Jorge
Salgado Fernández
Hospital Universitario de Valladolid
Valladolid, EspañaPublications in collaboration with researchers from Hospital Universitario de Valladolid (2)
2022
-
Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial
European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588
2013
-
Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: Insights from a large multicenter registry
Journal of the American College of Cardiology, Vol. 62, Núm. 17, pp. 1552-1562